BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Gatuzosiran readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Gatuzosiran\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06613698-6673@assetmemo.bio
DTSTAMP:20261121T005740Z
DTSTART;VALUE=DATE:20271126
DTEND;VALUE=DATE:20271127
SUMMARY:Gatuzosiran: Phase 2 readout est. (NCT06613698)
DESCRIPTION:Gatuzosiran\, phase 2.\nStudy: A Study to Investigate the Safet
 y and Efficacy of GSK4532990 Compared With Placebo in Adult Participants A
 ged 18 to 70 Years With Alcohol-related Liver Disease\nEstimated primary c
 ompletion: 26 November 2027. This is a ClinicalTrials.gov estimate\, not a
  confirmed readout date\, and it can move.\nDrug page: https://assetmemo.b
 io/drug/gatuzosiran#upcoming-events\nRegistry record: https://clinicaltria
 ls.gov/study/NCT06613698
URL:https://assetmemo.bio/drug/gatuzosiran#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
